2001, Número 4
<< Anterior Siguiente >>
Rev Fac Med UNAM 2001; 44 (4)
Mortalidad por disfunción orgánica múltiple en una unidad de cuidados intensivos
Carrillo ER, Téllez MMA, Salinas RS
Idioma: Español
Referencias bibliográficas: 25
Paginas: 156-160
Archivo PDF: 56.22 Kb.
RESUMEN
Objetivo: Estudiar la mortalidad por disfunción orgánica múltiple en una Unidad de Cuidados Intensivos. Estudio documental retrospectivo.
Resultado: De 43 pacientes que desarrollaron el síndrome durante este período de tiempo 19 murieron y 24 sobrevivieron. Los pacientes que sobrevivieron presentaron menos de 2 fallas y éstas revirtieron. Los pacientes que murieron presentaron 2 o más fallas que no revirtieron.
Los factores de riesgo para disfunción orgánica múltiple en este grupo fueron: edad mayor de 70 años, intensidad del daño, choque, transfusión múltiple, sepsis. La mortalidad aumentó conforme más órganos fueron afectados. Con una mortalidad del 21% para 2 fallas, 68% para 3 fallas y 100% cuando hubo falla en 4 órganos o sistemas.
Conclusión: El síndrome de disfunción orgánica múltiple es un fenómeno complejo cuya evolución está determinada por la interacción dinámica de un evento desencadenante y la respuesta del huésped a este estímulo. Aún no se ha determinado si la evolución final refleja la expresión variable de un solo proceso patogénico o es la expresión semejante de diversos procesos biológicos.
REFERENCIAS (EN ESTE ARTÍCULO)
Xiandong Wang. The Role of Endothelial Cells in the Systemic Inflammatory Response Syndrome and Multiple System Organ Failure. Eur J Surg 1995; 161: 703-713
Bone RC, M.D. Immunologic Dissonance: A continuing Evolution Our Understanding in the Systemic Inflammatory Response Syndrome (SIRS) and Multiple Organ Dysfunction Syndrome (MODS). Ann Intern Med. 1996; 125: 680-687.
Baue AE, MD. Multiple Organ Failure, Multiple Organ Dysfunction Syndrome, and Systemic Inflammatory Response Syndrome. Arch Surg 1997; 132: 703-707.
Bone RC, MD, Charles J. Grodzin MD. Sepsis: A new Hypothesis for Pathogenesis of the Disease Process. Chest 1997; 112: 235-243.
Pastor CM, MD and Suter P. Hepatic Hemodynamics and Cell Functions in Humans and Experimental Sepsis. Anesth Analg 1999; 89: 344-52.
Satoshi Gando, MD, Takashi Kameue, MD. Participation of tissue factor and thrombin in posttraumatic systemic inflammatory syndrome. Crit Care Med 25: 1820-1826.
Salvo A. Wolfer, Montani C. The Italian SEPSIS study: preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Med 1995; 21: S244-S249.
Marietta J, Bertleff O and Hajo. Briuning. How should multiple organ dysfunction syndrome be assessed? A review of the variations in current scoring systems. Eur J Surg 1997; 163: 405-409.
Sydney Jacobs MB, Mehrun Zuleika MB. The multiple organ dysfunction score as a descriptor of patient outcome in septic shock compared with two other scoring systems. Cri Care Med 1999; 27: 741-744.
Evans TW, Smithies M. ABC of intensive care. Organ dysfunction. BMJ 1999; 138: 1606-1608.
Members of the American College of Chest physicians/Society of Critical Care Medicine Consensus Conference Committee. American College of Chest Physicians/ Society of Critical Care Medicine Consensus Conference: Definitions for Sepsis and Organ Failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-874.
MICU, St. Vincent Hospital, University of Massachusetts Medical School. The hemodinamic deragements in Sepsis. Chest 1998; 114: 854-861.
Yoshio Haga MD, Toru Beppu MD. Systemic inflammatory response syndrome and organ dysfunction following gastrointestinal surgery. Critical Care Med 1997; 25: 1994-2000.
Balk RA, MD. Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock. Critical Care Clinics 2000; 16(2).
Garrison N, MD, Spain DA, MD, Microvascular Changes explain the “ Two-Hit” theory of multiple organ failure. Annals of Surgery 1998; 227: 851-860.
Crouser ED, MD, Dorinsky PM, MD. Metabolic consequences of sepsis. Clinics Chest Medicine; 17: 249-261.
Anad Kumar MD. Inotropes and gut mucosal perfusión: A brake on the motor of multiple organ failure. Critical Care Medicine; 25: 166-167.
Kirton O, MD. Windsor J, MD. Failure of splachnic in the acutely injured trauma patient correlates with multiple organ system failure and length of stay in the UCI. Clinics in Chest Medicine 1996; 17(2): 249-51.
Deitch E, Goodman E, MD. Prevention of multiple organ failure. Surgical Clinics of Norteamerica. 1999; 79(6).
Borrelli E, MD, Roux LP, MD. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Critical Care Medicine 1996; 24: 391-397.
Rangel F, MD, Pittet Didier MD. The natural history of the systemic inflammatory response syndrome (SIRS). JAMA 1995; 273: 117-123.
Gomersall Charles, Gavin Joint. Resuscitation of critically ill patients based on the results of gastric tonometry: a prospective study, randomized, controlled trial. Critical Care Medicine 2000; 28: 607-614.
Slutzky AS, Liu M. Antiinflamatory therapies: application of molecular biology techniques in intensive care medicine. Intensive Care Med 1997; 23: 718-731.
Deutschman Cliford MS, MD. Acute phase response and SIRS/MODS: the good, the bad, and the nebulous. Critical Care Medicine 1998; 26: 630-632.
McCarty S, Katz D. Splachnic ischemia and gut mucosal injury in sepsis and the multiple organ dysfunction syndrome. American Journal of Gastroenterology 1996; 91: 1697-1710.